| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 03/06/2001 | US6197853 Polycarbonate composition resistant to gamma radiation |
| 03/06/2001 | US6197824 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 03/06/2001 | US6197817 Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders |
| 03/06/2001 | US6197770 Alkenyl- and alkynl-containing metalloprotease inhibitors |
| 03/06/2001 | US6197506 Using substrate having over 100 different polynucleotides at density of over 50 different polynucleotides per square centimeter to generate hybridization patterns and distinguish between two nucleic acid samples; heredity; diagnosis |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014364A1 Fatty acid synthase inhibitors |
| 03/01/2001 | WO2001014363A1 Fatty acid synthase inhibitors |
| 03/01/2001 | WO2001014362A1 Fatty acid synthase inhibitors |
| 03/01/2001 | WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 03/01/2001 | WO2001014328A2 Substituted ureas as cell adhesion inhibitors |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014303A1 Triketone compounds, process for producing the same and herbicides containing the same |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2384197A1 Fatty acid synthase inhibitors |
| 03/01/2001 | CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 02/28/2001 | EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient |
| 02/28/2001 | EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077698A1 Metabolites of ecteinascidin 743 |
| 02/28/2001 | CN1285352A Preparation for lignal like material |
| 02/27/2001 | US6194612 Template for solution phase synthesis of combination libraries |
| 02/27/2001 | US6194589 Production of amide derivatives and intermediate compounds therefor |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | US6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors |
| 02/22/2001 | WO2001012585A1 Fungicidal compounds having a fluorovinyl- or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof |
| 02/22/2001 | WO2000078724A3 Imidazolinderivatives their preparation and their pharmaceutical use |
| 02/22/2001 | WO2000071500A8 Halogen compounds |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | DE19939516A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives, as microsomal triglyceride transfer protein inhibitors useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia |
| 02/21/2001 | EP1076654A2 Method for the continuous production of 1,3-dioxolan-2-ones |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/21/2001 | CN1062262C Substituted vinylurea derivatives and medicine containing the same |
| 02/20/2001 | US6191170 Benzenesulfonamides and benzamides as therapeutic agents |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/20/2001 | CA2191789C Biaromatic compounds containing an adamantyl group in ortho position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 02/20/2001 | CA2173065C Process for removal of diol as impurity in cyclic carbonic acid ester |
| 02/15/2001 | WO2001010843A1 4-(substituted phenyl)-5-halopyrimidine derivatives and herbicides containing the same as the active ingredient |
| 02/15/2001 | WO2001010834A2 Antibacterial agents |
| 02/15/2001 | WO2001010816A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/14/2001 | CN1284072A Prodrugs of aspartyl protease inhibitors |
| 02/13/2001 | US6187965 Process for recovering high boiling solvents from a photolithographic waste stream comprising at least 10 percent by weight of monomeric units |
| 02/13/2001 | US6187933 Bind to retinoid receptors; treating skin disorders |
| 02/13/2001 | US6187842 Sugar compounds, gelling agents, gelling agent compositions processes for the preparation of them, and gel compositions |
| 02/13/2001 | CA2147808C Acetylenic biaromatic compounds containing an adamantyl group; pharmaceutical and cosmetic compositions containing them and uses thereof |
| 02/08/2001 | WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073626A1 Azine used as fungicides |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | EP1073428A1 Dihydroxyphenyl derivatives for hepatoprotection and treatment of liver diseases |
| 02/07/2001 | EP0562025B1 Compounds and their use in a binary synthesis strategy |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas |
| 02/01/2001 | WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 02/01/2001 | DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production |
| 01/31/2001 | EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/31/2001 | EP1071660A1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/31/2001 | EP1071656A1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same |
| 01/31/2001 | EP0975620A4 Novel synthesis of myo-inositol phosphates |
| 01/31/2001 | CN1282326A Anilide derivative, production and use thereof |
| 01/30/2001 | US6180823 Stereoselective process for alkyl phenylglycolic acids |
| 01/30/2001 | US6180800 Electrolytes for batteries |
| 01/30/2001 | US6180785 Process for preparing diltiazem |
| 01/30/2001 | US6180675 IL-8 receptor antagonists |
| 01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
| 01/24/2001 | CN1281444A Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 01/24/2001 | CN1281335A Treatment of schizophrenia with ampakines and neuroleptics |
| 01/23/2001 | US6177586 Vitamin D3 derivative and production process thereof |
| 01/23/2001 | US6177576 Pyruvate saccaride ketals |
| 01/23/2001 | US6177459 Substituted heterocyclic compounds and their use as fungicides |
| 01/23/2001 | US6177400 Improving or modifying the odor of a perfume by adding 4,6,6-trimethyl-1,(3)-cyclohex(adi)ene 1-substituted with esters, ethers or ketones, such as (e)-1-(4,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one |
| 01/18/2001 | WO2001004122A2 New 2,3-benzodiazepine derivatives |
| 01/18/2001 | WO2001004108A1 Amino ceramide-like compounds and therapeutic methods of use |
| 01/18/2001 | CA2378600A1 Amino ceramide-like compounds and therapeutic methods of use |
| 01/18/2001 | CA2378305A1 New 2,3-benzodiazepine derivatives |
| 01/17/2001 | EP1068200A1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 01/17/2001 | EP1068178A1 NON-PEPTIDE GnRH AGENTS |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | CN1280128A Process for preparing cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetralin-1-group)phenoxy]ethyl} pyrrolidine |
| 01/16/2001 | US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound |
| 01/16/2001 | US6174711 Method for producing L-allysine acetal |
| 01/11/2001 | WO2001002474A1 Polycarbonate composition resistant to gamma radiation |
| 01/11/2001 | WO2001002349A1 Phenyl sulfamate derivatives |
| 01/11/2001 | DE19931116A1 Verfahren zur Herstellung von Phenethylaminen und neue chemische Verbindungen Process for the preparation of novel chemical compounds and phenethylamines |
| 01/11/2001 | CA2377717A1 Polycarbonate composition resistant to gamma radiation |
| 01/10/2001 | EP1067113A2 Process for the preparation of phenethylamines and intermediates therefor |
| 01/10/2001 | EP1067109A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 01/10/2001 | EP1066282A1 Novel cationic di-methylenedioxy-benzenes, their use for oxidation dyeing of keratin fibres |
| 01/10/2001 | EP1066281A1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods |
| 01/10/2001 | EP1066259A1 Biocidal benzylbiphenyl derivatives |
| 01/10/2001 | EP1066246A1 Novel cationic couplers and their use for oxidation dyeing |
| 01/09/2001 | US6172229 1-phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands |
| 01/09/2001 | US6172182 Process for the manufacture of epoxy compounds |
| 01/09/2001 | US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 01/09/2001 | US6172103 Treating bone disorders, osteoporosis, and arthritis |
| 01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/04/2001 | WO2001000566A2 Substituted phenoxyacetic acids |